Group 1: Manufacturing Sector Insights - July Manufacturing PMI stands at 49.3%, below the expected 49.7% and previous value of 49.7%[1] - New orders in manufacturing decreased by 0.8 percentage points to 49.4%, while production fell by 0.5 percentage points to 50.5%[1] - Manufacturing new export orders dropped by 0.4 percentage points to 47.1%, slightly below the first half average of 47.3%[2] Group 2: Price and Demand Dynamics - Raw material purchase price index increased by 3.1 percentage points to 51.5%, while factory prices rose by 2.1 percentage points to 48.3%[3] - Procurement volume declined by 0.7 percentage points to 49.5%, indicating insufficient demand constraints[3] - Finished goods inventory decreased by 0.7 percentage points to 47.4%, reflecting a preference for reducing stock rather than increasing production[3] Group 3: Non-Manufacturing Sector Trends - Non-manufacturing PMI recorded at 50.1%, down from 50.5% in the previous month[1] - Construction activity index and new orders both fell by 2.2 percentage points, while service sector indices saw minor declines[4] - Employment indices in construction and manufacturing improved by 1.0 and 0.1 percentage points respectively, indicating a slight recovery in job markets[4] Group 4: Economic Outlook and Market Implications - Overall economic slowdown in July attributed to adverse weather conditions and previous export surges[5] - The composite PMI for July is at 50.2%, matching levels from April and July of the previous year[6] - Market risk appetite may be affected by the July PMI results, leading to potential volatility in stock markets[5]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook on its future performance [7]. Core Insights - The company is a leading domestic player in ultrasonic equipment, experiencing a short-term performance inflection point due to strong growth in lithium battery production and rapid adoption of new products [3][25]. - The company has established a comprehensive ultrasonic technology platform, which supports its long-term growth logic by enabling expansion into various high-growth sectors such as solid-state batteries, medical devices, and robotics [4][54]. - The traditional lithium battery sector is recovering, with significant demand for ultrasonic welding equipment, particularly in multi-layer ear welding applications, which are critical for battery performance [63][69]. Summary by Sections Section 1: Domestic Ultrasonic Equipment Leader - The company specializes in ultrasonic equipment, with products including power battery welding equipment, automotive wiring harness welding equipment, and semiconductor ultrasonic devices, serving leading players in each segment [9][12]. - The revenue from the power battery segment has historically been the main driver of growth, with a CAGR of 48% from 2018 to 2022 [25][27]. Section 2: Mastery of Ultrasonic Platform Technology - The company has built a robust ultrasonic technology platform that spans theoretical, technical, and product levels, allowing for continuous innovation and revenue generation [4][54]. - The competitive landscape shows that the company faces high barriers to entry, with competitors primarily being foreign leaders, which enhances its profitability [4][57]. Section 3: Power Battery Sector - The recovery of traditional lithium batteries is evident, with major players like CATL and BYD restarting production, leading to a clear revival in demand for ultrasonic welding equipment [5][69]. - The company expects significant revenue growth from the power battery segment, with projected revenues of 1.5 billion yuan in 2024, supported by a high market share in ear welding applications [72]. Section 4: 3D Packaging as a Key Growth Area - The company is well-positioned to benefit from the expansion of advanced packaging technologies, with projected revenues from semiconductor equipment expected to grow significantly [6][54]. - The demand for ultrasonic scanning microscopes is anticipated to increase as traditional inspection methods become less effective in advanced packaging scenarios [6][54]. Section 5: Investment Recommendations - The report forecasts revenues of 7.58 billion, 10.44 billion, and 14.46 billion yuan for 2025-2027, with corresponding net profits of 1.40 billion, 2.25 billion, and 3.42 billion yuan, indicating strong growth potential [7].

证券研究报告|港股公司点评报告 [Table_Date] 2025 年 07 月 31 日 [Table_Title] 25H1 净利润超预期，上调盈利预测 公司公告 2025 年中报净利增长 45-50%，超出市场预期。公司净利增加主要由于（1）上半年新生注册机新 客户注册数量增加约 7%，从而导致收入增加约 10%；（2）上半年公司高效的运营及成本控制，使得整体成本 在收入增长的情况下，仍能保持平稳。 分析判断: 我们分析，公司收入增长主要由于 15 个月高价格专业占比提升、职教升学、美业增长超预期带动，利润 为高经营杠杆效应的体现。 投资建议 我们分析，（1）短期来看，我们预计公司秋季招生良好，随着成本控制全年业绩有望持续超预期；（2）中 期来看，在长期生招生恢复的基础上，明后年收入有望加速增长；分品类来看，我们预计烹饪招生恢复、汽车和 美业维持快速增长，欧米奇和美业减亏趋势持续、汽车服务净利率提升；（3）公司长期优势在于就业竞争力、 针对市场变化快速调节课程的能力，公司区域中心建设完成后、技师学院资质获批、从而有望拉长学制。上调盈 利预测，上调 25-27 年营业收入预测 44.1/48.4/53.2 ...

Investment Rating - The investment rating for the company is "Buy" [1][6]. Core Views - The company reported a significant increase in revenue and net profit for the first half of 2025, with revenue reaching 1.39 billion yuan, up 30.45% year-on-year, and net profit of 138 million yuan, up 51.52% year-on-year [2]. - The veterinary pharmaceutical segment showed remarkable performance, with revenue of 860 million yuan, a year-on-year increase of 72.15%, accounting for 61.83% of total revenue [3]. - The vaccine segment maintained a stable foundation despite a slight revenue decline, with income of 155 million yuan, down 0.92% year-on-year, representing 11.12% of total revenue [4]. - The company is well-positioned to benefit from domestic and international market demand growth, cost optimization, and price increases, particularly in the veterinary pharmaceutical sector [5]. Summary by Sections Financial Performance - The company achieved a total revenue of 2.371 billion yuan in 2024, projected to grow to 2.835 billion yuan in 2025, and further to 3.030 billion yuan in 2026 [10]. - The net profit is expected to rise from 100 million yuan in 2024 to 197 million yuan in 2025, and 326 million yuan in 2026 [10]. - The gross margin is projected to be 33.5% in 2024, decreasing slightly to 31.9% in 2025, and then increasing to 36.4% in 2026 [10]. Business Segments - The veterinary pharmaceutical segment's gross margin was 38.13%, despite a slight year-on-year decrease due to lower-margin product sales [3]. - The vaccine segment's gross margin was 54.87%, down 5.50 percentage points year-on-year, influenced by increased market competition and customer cost-cutting [4]. - The company is expanding its product pipeline with over 20 products in research and registration, including new vaccines for various diseases [4]. Future Outlook - The company is expected to maintain a dual-driven strategy with its pharmaceutical and vaccine segments, supported by ongoing research and development efforts [5]. - The projected earnings per share (EPS) are expected to increase from 0.13 yuan in 2024 to 0.26 yuan in 2025, and 0.42 yuan in 2026 [10].

Investment Rating - The report recommends a "Buy" rating for the industry, indicating a positive outlook for the sector's performance relative to the benchmark index [5]. Core Insights - The lithium business, particularly the Greenbushes lithium mine, showed a production volume of 340,000 tons in Q2 2025, reflecting a 2% year-on-year increase, while sales volume decreased by 22% to 412,000 tons [1][3]. - The average realized price for lithium concentrate was $725 per ton, down 8% from the previous quarter [1]. - The Kwinana lithium hydroxide plant produced 2,126 tons in Q2 2025, a 36% increase quarter-on-quarter and a 60% increase year-on-year, although sales volume decreased by 25% [4][6]. - The nickel business at the Nova project reported a production of 5,107 tons in Q2 2025, a 22% increase quarter-on-quarter, but a 20% decrease year-on-year [8]. Summary by Sections Lithium Business - Greenbushes lithium mine produced 340,000 tons in Q2 2025, with a cash production cost of A$366 per ton, up 8% year-on-year [1][3]. - Kwinana hydroxide plant's production was 2,126 tons, with a conversion cost of A$17,215 per ton, down 20% from the previous quarter [4][7]. Nickel Business - Nova project achieved a nickel production of 5,107 tons in Q2 2025, with a cash cost of A$3.97 per pound, down 23% quarter-on-quarter [8]. - The average realized price for nickel decreased to A$23,261 per ton, a 7% decline from the previous quarter [8]. Financial Performance - The company's revenue for Q2 2025 was A$126.9 million, a 15% increase quarter-on-quarter but a 46% decrease year-on-year [10]. - The underlying EBITDA for Q2 2025 was A$62.3 million, compared to A$34 million in the same quarter last year [11]. Production Guidance - For FY25, the Greenbushes lithium production guidance is set at 1,350,000 to 1,550,000 tons, with a cash cost guidance of A$320 to A$380 per ton [19]. - The Kwinana refinery's production guidance for FY25 is 7,000 to 8,000 tons of lithium hydroxide [19].

Investment Rating - The report provides a "Buy" rating for the industry, indicating a forecasted stock price increase of 15% or more relative to the Shanghai Composite Index within six months following the report's release [27]. Core Insights - The lithium concentrate production for Q2 2025 reached 144,000 tons, representing an 8% quarter-on-quarter increase, while the shipment volume was 135,000 tons, up 6% from the previous quarter [1]. - The average realized price for lithium concentrate in Q2 2025 was $642 per ton, reflecting a 24% decrease compared to the previous quarter [1]. - The report highlights significant production and shipment variations across different mining sites, with Wodgina showing a 32% increase in production and a 15% increase in shipments for Q2 2025 [4][5]. Summary by Sections Lithium Mining - **Overall Performance**: In Q2 2025, the total lithium concentrate production was 144,000 tons, with shipments at 135,000 tons, marking increases of 8% and 6% respectively [1]. - **MT MARION**: Production decreased by 11% quarter-on-quarter to 124,000 tons, with shipments down 3% to 134,000 tons. The average realized price fell by 28% to $607 per ton [2]. - **WODGINA**: Production increased by 32% to 166,000 tons, with shipments rising 15% to 136,000 tons. The average realized price was $674 per ton, down 20% [7]. Iron Ore Mining - **ONSLOW IRON**: Achieved commercial production with a Q2 2025 output of 6.18 million tons, an 80% increase quarter-on-quarter. The average realized price was $79 per ton, down 11% [8][9]. - **PILBARA HUB**: Produced 2.75 million tons in Q2 2025, a 9% increase, with an average price of $78 per ton, down 13% [10]. Financial Overview - As of June 30, 2025, the company had liquidity exceeding 1.1 billion AUD, including over 400 million AUD in cash [14]. - The net debt was approximately 5.35 billion AUD, with a significant reduction in borrowings due to positive cash flow from operations [15][16].

Investment Rating - The report recommends a "Buy" rating for the industry, predicting that the industry index will outperform the Shanghai Composite Index by 10% or more during the specified period [6]. Core Insights - The NAL project achieved a lithium concentrate production of 58,533 tons in Q2 2025, reflecting a 35% quarter-on-quarter increase, with an average grade of 5.2% Li₂O [2][12]. - The sales volume of lithium concentrate reached 66,980 tons in Q2 2025, marking a significant 148% increase compared to the previous quarter [3][12]. - The average realized selling price (FOB) decreased by 8% to 1,054 AUD per dry ton, influenced by shipping costs as two batches were sold to Piedmont Lithium and the international market [4][12]. - The unit operating cost for lithium concentrate (FOB) fell by 10% to 1,232 AUD per dry ton, with a 5% decrease in USD terms to 791 USD per dry ton [5][12]. - NAL's revenue for Q2 2025 was 71 million AUD, a 129% increase quarter-on-quarter, driven by higher sales volumes despite lower average selling prices [9][12]. Production and Operational Performance - In Q2 2025, the ore mined was 361,883 wet tons, a 12% increase from the previous quarter, with a focus on ensuring sufficient raw material supply for the mill [1][12]. - The recovery rate for lithium reached a record 73%, up 4 percentage points from Q1 2025, attributed to improved operational management and process enhancements [1][12]. - The processing plant's utilization rate hit a new high of 93%, significantly up from 80% in Q1 2025, due to limited planned maintenance and minimal unplanned downtime [1][12]. Inventory and Financial Position - As of June 30, 2025, NAL's total inventory of lithium concentrate was 25,221 tons, down from 34,881 tons at the end of Q1 2025 [8][12]. - The cash and cash equivalents balance was 72.3 million AUD, a decrease of 16.6 million AUD from March 31, 2025, primarily due to operational losses [9][12]. Merger and Strategic Developments - The merger between Sayona Mining Limited and Piedmont Lithium Inc. is set to be completed by September 1, 2025, following the necessary regulatory approvals [10][12].

Investment Rating - The report recommends a "Buy" rating for the industry, predicting that the industry index will outperform the Shanghai Composite Index by 10% or more in the upcoming period [5]. Core Insights - In Q2 2025, the company produced 85,892 tons of lithium concentrate, a 10% decrease from Q1 2025, while sales increased by 4% to 97,330 tons [1][2]. - The average realized price for lithium concentrate (SC6) in Q2 2025 was $740 per ton, down 9% from $815 in Q1 2025 [2]. - The unit operating cost (FOB) for sold lithium concentrate rose by 31% to $576 per ton, reflecting increased sorting costs and reduced inventory [2]. - The company reported a revenue of 96 million AUD in Q2 2025, an 8% decrease from 104 million AUD in Q1 2025, primarily due to the decline in average realized prices [3]. Production and Sales Summary - Q2 2025 lithium concentrate production: 85,892 tons, down 10% from Q1 2025 [1]. - Q2 2025 lithium concentrate sales: 97,330 tons, up 4% from Q1 2025 [1]. - Q2 2025 average realized price for SC6: $740 per ton, down from $815 in Q1 2025 [2]. - Q2 2025 unit operating cost (FOB): $576 per ton, up from $440 in Q1 2025 [2]. - Q2 2025 cash balance: 156 million AUD [4]. Financial Metrics - Q2 2025 net cash inflow from operating activities: 23 million AUD [7]. - Q2 2025 net cash outflow limited to 17 million AUD due to business optimization efforts [7]. - Expected non-cash impairment of inventory between 75 million to 85 million AUD for the fiscal year 2025 [8]. Future Guidance - For FY 2026, production guidance is set at 365,000 to 450,000 tons, reflecting a growth of 24% to 53% compared to FY 2025 [10]. - The company plans to transition to 100% underground mining operations in FY 2026, focusing on operational and strategic discipline [9]. - Unit operating costs for FY 2026 are expected to range from 855 to 1,045 AUD per ton [13].

Group 1: Federal Reserve Stance - Federal Reserve continues to pause interest rate cuts, indicating a shift from "economic activity continues to expand steadily" to "economic activity growth has slowed in the first half of the year" [1] - Powell's hawkish stance suggests that asserting a rate cut in September is premature, with inflation outlook showing mixed signals [1] - Market's expectation for rate cuts has retracted by 10 basis points, with the CME FedWatch indicating a drop from 45 basis points to 35 basis points for the year [1] Group 2: Economic Indicators - Labor market indicators such as turnover rates, job vacancies, and unemployment rates are close to levels from a year ago, indicating no significant weakness [1] - Employment creation and labor supply are slowing, presenting downside risks to the labor market [1] - The market is now leaning towards a single rate cut for the year, with expectations for a potential shift towards rate cut anticipation in August if tariff impacts on inflation remain manageable [2] Group 3: Market Reactions - Following the announcement, the US dollar index rose approximately 0.5%, nearing 100, while the 10-year Treasury yield increased from 4.34% to around 4.38% [1] - The market's confidence in a rate cut in October has decreased to about 80% following the meeting [1] - The overall economic data rebound and retraction of rate cut expectations are expected to support the dollar, although future agreements remain uncertain [2]

证券研究报告|行业点评报告 [Table_Date] 2025 年 7 月 30 日 [Table_Title] 中国香港稳定币监管制度核心要点 [Table_Title2] 计算机 行业评级: 推荐 [Table_Summary] 事件概述: 2025 年 7 月 29 日，为配合 8 月 1 日正式实施的稳定币发行人监管制度，中国香港金融管理局举办技术简报会， 发布发牌制度摘要等系列监管文件，明确稳定币发行人牌照申请要求、发牌时间表等。此前，中国香港金管局 已在《稳定币条例》基础上，发布《持牌稳定币发行人监管指引》及咨询总结等多份文件，其中两套指引将于 8 月 1 日刊宪，核心是明确发行或推广相关稳定币须申请牌照，并对申请人进行明确规定限制，设立 6 个月过渡 期，鼓励相关机构及时沟通申请。 核心观点: ► 高门槛牌照筛选，保障行业稳健起步 中国香港金管局为稳定币发行人设置了极高的牌照申请门槛，要求申请人须为中国香港注册法团或认可机构，拥 有持续的流动净资产来源，且实缴资金不少于 2500 万港元。我们认为，高门槛筛选能为稳定币行业奠定稳健发 展基础，初期少量牌照发放可让监管机构集中精力监管，促使获牌机构 ...